This reduction promotes the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and signal transducer and activator of transcription 3 (STAT3) signaling pathways, ultimately promoting enhanced tumor growth and metastasis (Yin et al., 2021). The gene discussed is NFKB1; the disease is neoplasm.